| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |